Zhejiang, China

Bo Wu

This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Converd Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Wu. Retrieved from https://idiyas.com/inventor/bo-wu-umlv61c2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bo Wu: Innovator in Immunotherapy

Introduction

Bo Wu is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of immunotherapy, particularly through his innovative approaches to cancer treatment. His work focuses on developing individualized systemic immunotherapeutic methods that enhance the body's immune response against tumors.

Latest Patents

Bo Wu holds a patent for an "In vivo individualized systemic immunotherapeutic method and device." This invention provides a comprehensive method that includes several key steps. Firstly, it increases the release amount of tumor antigens at the tumor site. Secondly, it enhances the level of proteins that can adhere to or wrap the tumor antigens. Thirdly, it boosts the level of dedicated antigen-presenting cells involved in immunity, establishing a close connection with immune effector cells to activate them. Lastly, it improves the level and function of immune effector cells at the tumor site. This innovative approach combines oncolytic therapy and immunotherapy, resulting in significantly improved therapeutic effects.

Career Highlights

Bo Wu is associated with Hangzhou Converd Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize cancer treatment through personalized medicine. With a focus on enhancing immune responses, Wu's contributions are paving the way for more effective therapeutic strategies.

Collaborations

Bo Wu collaborates with notable colleagues, including Fang Hu and Ronghua Zhao. Their combined expertise in the field of immunotherapy enhances the research and development efforts at Hangzhou Converd Co., Ltd.

Conclusion

Bo Wu's innovative work in immunotherapy exemplifies the potential of individualized treatment methods in combating cancer. His patent and ongoing research contribute significantly to the advancement of medical science, offering hope for improved therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…